An unusual association of pemphigus vulgaris with hyperprolactinemia

International Journal of Dermatology

Volumn 41, Issue 10, 2002, Pages 696-699

  Khandpur, Sujay ^a,b   Reddy, Belum Sivanagi ^a  

^a LOK NAYAK HOSPITAL   (India)

^b Hauz Khas Apartments   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIEMETIC AGENT; BROMOCRIPTINE MESILATE; COMPLEMENT COMPONENT C3; HEMOGLOBIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G ANTIBODY; PREDNISOLONE; PROCTINAL; PROLACTIN; STEROID;

ADULT; ANAMNESIS; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; BASEMENT MEMBRANE; BODY REGIONS; BREAST ENGORGEMENT; BULLOUS SKIN DISEASE; CASE REPORT; CLINICAL FEATURE; CONFERENCE PAPER; CONVALESCENCE; DISEASE ASSOCIATION; DISEASE DURATION; DRUG EFFECT; EPIDERMIS; EPITHELIZATION; ERYTHROCYTE SEDIMENTATION RATE; FEMALE; GALACTORRHEA; HEMOGLOBIN DETERMINATION; HISTOLOGY; HUMAN; HYPERPROLACTINEMIA; IDIOPATHIC DISEASE; IMMUNOFLUORESCENCE TEST; LEUKOCYTE COUNT; LEUKOCYTE DIFFERENTIAL COUNT; LYMPHOCYTE COUNT; MAINTENANCE THERAPY; MENSTRUAL IRREGULARITY; MOUTH ULCER; NAUSEA; PEMPHIGUS VULGARIS; PROLACTIN BLOOD LEVEL; PROTEIN ELECTROPHORESIS; PRURITUS; RELAPSE; SKIN DEFECT; SKIN EXAMINATION; SMEAR; STATISTICAL SIGNIFICANCE; TABLET; VERTIGO;

ADULT; FEMALE; HUMANS; HYPERPROLACTINEMIA; PEMPHIGUS;

EID: 0036773870     PISSN: 00119059     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-4362.2002.01393_1.x     Document Type: Conference Paper

References (23)

1. Becker BA, Gaspari AA. Pemphigus vulgaris and vegetans, Dermatol Clin 1993; II: 429-452.
2. From E, Frederiksen P. Pemphigus vulgaris following D-penicillamine. Dermatologica 1976; 152: 358-362.
3. Katz RA, Hood AF, Anhalt GJ. Pemphigus-like eruption from captopril. Arch Dermatol 1987; 123: 20-21.
4. Honey JF, Eguiguren G, Pinto A, et al. Bullous dermatoses of pregnancy. Arch Dermatol 1981; 117: 264-267.
5. Mignogna MD, Muzio LL, Ruocco E. Pemphigus induction by influenza vaccine. Int J Dermatol 2000; 39: 795-800.
6. Saikia NK. Extraction of pemphigus antibodies from a lymphoid neoplasm and its possible relationship to pemphigus vulgaris. Br J Dermatol 1972; 86: 411.
7. Korman NJ, Eyre RW, Zone J, Stanley JR. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus. J Invest Dermatol 1991; 96: 273-276.
8. Jara JJ, Lavalle C, Fraga A, et al. Prolactin, immunoregulation and autoimmune diseases. Semin Arthritis Rheum 1991; 20: 273-284.
9. Bongiovanni AM. Prolactin: A review with pediatric clinical implications. Adv Pediatr 1995; 32: 349-368.
10. Chikanza IC, Panayi GS. Hypothalamic-pituitary mediated modulation of immune function: prolactin as a neuroimmune peptide. Br J Rheumatol 1991; 30: 203-207.
11. Morris DR, Allen ML, Rabinovitch PS, et al. Mitogenic signalling pathways regulating expression of c-myc and ornithine decarboxylase genes in bovine T-lymphocytes. Biochemistry 1988; 27: 8689-8692.
12. Buckle AR, Crow PD, Pulnam CW, Russell DH. Rapid activation of rat liver protein kinase by prolactin in vitro and by partial hepatectomy. FASEB J 1989; 3: Abstract 27.
13. Ferrari C, Boghen M, Paracchi A, et al. Thyroid autoimmunity in hyperprolactinemic disorders. Acta Endocrinol (Copenh) 1983; 104: 35-41.
14. Lever EG, Mckerron CG. Autoimmune Addison's disease associated with hyperprolactinemia. Clin Endocrinol 1984; 21: 451-457.
15. Asa SL, Bilbao JM, Kova CSK, et al. Lymphocytic hypophysitis of pregnancy resulting in hypopituitarism: a distinct clinico-pathologic entity. Ann Intern Med 1981; 95: 166-171.
16. Hedner LP, Bynke G. Endogenous iridocyclitis relieved during treatment with bromocriptine. Am J Opthalmol 1985; 100: 618-619.
17. Azar ST, Yamout B. Prolactin secretion is increased in patients with multiple sclerosis. Endocrine Res 1999; 25: 207-214.
18. McMurray RW, Allen SH, Pepmueller PH, et al. Elevated serum prolactin levels in children with juvenile rheumatoid arthritis and antinuclear antibody seropositivity. J Rheumatol 1995; 22: 1577-1590.
19. Buskila I, Sukenik S, Holcberg G, Horowitz J. Improvement of psoriatic arthritis in a patient treated with bromocriptine for hyperprolactinemia. J Rheumatol 1991; 18: 611-612.
20. Regana MS, Millet PU. Psoriasis in association with prolactinoma: three cases. Br J Dermatol 2000; 143: 864-867.
21. Blank M, Palestine A, Nussenblatt R, et al. Down-regulation of autoantibody levels of cyclosporine and bromocriptine treatment in patients with uveitis. Clin Immunol Immunopathol 1990; 54: 87-97.
22. McMurray RW. Prolactin and systemic lupus erythematosus. Ann Med Interne (Paris) 1996; 147: 253-258.
23. Buskila D, Suskenik S, Shoenfeld Y. The possible role of prolactin in autoimmunity. Am J Reprod Immunol 19991 26: 118-123.